Richard Maziarz: Where We Are and Where Cell Therapy Is Going?
Richard Maziarz, Medical Director, Blood and Marrow Transplant, Cellular Therapy Program at Oregon Health and Science University, shared on LinkedIn about a recent article he and his colleagues co-authored, published in Transplantation and Cellular Therapy, adding:
”Where we are, where we are going?
That was the message delivered during the opening session at the Tandem meetings 2026: A summary of the CIBMTR/EBMT/ASTCT collaborative has just been published.
The work ahead is daunting but the future looks bright for cell therapy clinical care delivery.”
Title: Challenges with expansion of cell and gene therapy: A call for system-level action
Authors: Jeffery J. Auletta, Alvaro Urbano-Ispizua, Richard T. Maziarz, Anna Sureda, Sumithra Vasu, David L. Porter

Stay updated wih Hemostasis Today.
-
Nov 13, 2026, 02:07Tonie Reincke: Understanding Deep Vein Thrombosis and Vascular Health
-
Nov 13, 2026, 01:52Akshita Singh: The Remarkable Process of Blood Clotting
-
Nov 12, 2026, 22:52Milka Koupenova: The Role of Platelet RIG-I in Regulating Thrombotic Responses
-
Nov 12, 2026, 22:50Arun V J: Why Has India Still Not Achieved 100% Voluntary Blood Donation?
-
Nov 12, 2026, 22:49Sickle Cell Disease Deserves to Be Prioritised in Ghana – ISCC
-
Nov 12, 2026, 22:47Samir Kumar Beura: Delighted to Serve as a Topic Editor for a Research Topic in Frontiers in Neuroscience
-
Nov 12, 2026, 22:46Ashish Sharma: In-Hospital Mortality and Bleeding Complications in APL
-
Nov 12, 2026, 22:44Mary Cushman: New Position at the Vermont Center for Cardiovascular and Brain Health
-
Nov 12, 2026, 22:43Lama Alstanbuli: Discussing and Optimizing Stroke Pathways Across Healthcare Systems